Cargando…

Signature construction and molecular subtype identification based on immune-related genes for better prediction of prognosis in hepatocellular carcinoma

OBJECTIVE: Hepatocellular carcinoma (HCC) immunotherapy is a focus of current research. We established a model that can effectively predict the prognosis and efficacy of HCC immunotherapy by analyzing the immune genes of HCC. METHODS: Through the data mining of hepatocellular carcinoma in The Cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Liang, Wu, Zhengyi, Dong, Cairong, Yu, Shian, Huang, He, Chen, Zhendong, Wu, Zhipeng, Yin, Xiangbao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265900/ https://www.ncbi.nlm.nih.gov/pubmed/37316840 http://dx.doi.org/10.1186/s12920-023-01558-z

Ejemplares similares

Molecular subtype identification and signature construction based on Golgi apparatus-related genes for better prediction prognosis and immunotherapy response in hepatocellular carcinoma
por: Sun, Liang, et al.
Publicado: (2023)

Comprehensive Analysis of Prognostic Value and Immune Infiltration of Ficolin Family Members in Hepatocellular Carcinoma
por: Sun, Liang, et al.
Publicado: (2022)

Comprehensive Analysis of Cellular Senescence-Related Genes in Prognosis, Molecular Characterization and Immunotherapy of Hepatocellular Carcinoma
por: Sun, Liang, et al.
Publicado: (2022)

Signature Construction and Molecular Subtype Identification Based on Pyroptosis-Related Genes for Better Prediction of Prognosis in Hepatocellular Carcinoma
por: Chen, Ji, et al.
Publicado: (2022)

Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma
por: Peng, Xingyu, et al.
Publicado: (2022)

Pancancer analysis of oncogenic BARX2 identifying its prognostic value and immunological function in liver hepatocellular carcinoma
por: Yu, Shian, et al.
Publicado: (2023)

Identification of novel lactate metabolism signatures and molecular subtypes for prognosis in hepatocellular carcinoma
por: Guan, Qiutong, et al.
Publicado: (2022)

Tumor subtypes and signature model construction based on chromatin regulators for better prediction of prognosis in uveal melanoma
por: Li, Yue, et al.
Publicado: (2023)

Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy response in hepatocellular carcinoma
por: Zhu, Jinfeng, et al.
Publicado: (2023)

A Mitophagy-Related Gene Signature for Subtype Identification and Prognosis Prediction of Hepatocellular Carcinoma
por: Liu, Chang, et al.
Publicado: (2022)

Identification of DNA repair gene signature and potential molecular subtypes in hepatocellular carcinoma
por: Bai, Yi, et al.
Publicado: (2023)

A Ferroptosis and Pyroptosis Molecular Subtype-Related Signature Applicable for Prognosis and Immune Microenvironment Estimation in Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

A ubiquitin-related gene signature for predicting prognosis and constructing molecular subtypes in osteosarcoma
por: Wei, Nan, et al.
Publicado: (2022)

Prognosis-Related Molecular Subtypes and Immune Features Associated with Hepatocellular Carcinoma
por: Ye, Jiazhou, et al.
Publicado: (2022)

Identification of cuproptosis-based molecular subtypes, construction of prognostic signature and characterization of immune landscape in colon cancer
por: Wang, Xu, et al.
Publicado: (2023)

Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma
por: Chen, Fei, et al.
Publicado: (2022)

DLGAP4 acts as an effective prognostic predictor for hepatocellular carcinoma and is closely related to tumour progression
por: Dong, Cairong, et al.
Publicado: (2022)

Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma
por: Bai, Yang, et al.
Publicado: (2021)

Identification and validation of GABA‐driven subtypes and prognosis signature of lung adenocarcinoma
por: Li, Lifeng, et al.
Publicado: (2023)

Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma
por: Yu, Wanli, et al.
Publicado: (2021)

Identification of cuproptosis related subtypes and construction of prognostic signature in gastric cancer
por: Dong, Hao, et al.
Publicado: (2023)

Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
por: Hua, Linbin, et al.
Publicado: (2023)

Molecular subtyping of acute myeloid leukemia through ferroptosis signatures predicts prognosis and deciphers the immune microenvironment
por: Fu, Denggang, et al.
Publicado: (2023)

Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma
por: Peng, YunZhen, et al.
Publicado: (2022)

Identification of immune subtypes and their prognosis and molecular implications in colorectal cancer
por: Sun, Yan, et al.
Publicado: (2022)

Subtype Classification and Prognosis Signature Construction of Osteosarcoma Based on Cellular Senescence-Related Genes
por: Wang, Hanyu, et al.
Publicado: (2022)

Prediction of Prognosis in Patients with Hepatocellular Carcinoma Based on Molecular Subtypes of Immune Genes
por: Du, Suming, et al.
Publicado: (2022)

Identification of the molecular subtypes and construction of risk models in neuroblastoma
por: He, Enyang, et al.
Publicado: (2023)

Identification of molecular subtypes and prognostic signature for hepatocellular carcinoma based on genes associated with homologous recombination deficiency
por: Lin, Hongsheng, et al.
Publicado: (2021)

Identification of an eleven-miRNA signature to predict the prognosis of endometrial cancer
por: Lu, Jing, et al.
Publicado: (2021)

Platelet-Related Molecular Subtype to Predict Prognosis in Hepatocellular Carcinoma
por: Zhang, Genhao
Publicado: (2022)

Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer
por: Lin, Dagui, et al.
Publicado: (2021)

Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy
por: Li, Ruiyu, et al.
Publicado: (2021)

Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions
por: Zheng, Qiuxian, et al.
Publicado: (2021)

Construction and Validation of an Immune Cell Signature Score to Evaluate Prognosis and Therapeutic Efficacy in Hepatocellular Carcinoma
por: Xu, Linfeng, et al.
Publicado: (2021)

Construction and Validation of an Epigenetic Regulator Signature as A Novel Biomarker For Prognosis, Immunotherapy, And Chemotherapy In Hepatocellular Carcinoma
por: Cai, Jialiang, et al.
Publicado: (2022)

Identification of the Pyroptosis-Related Prognosis Gene Signature and Immune Infiltration in Hepatocellular Carcinoma
por: Yu, Heng, et al.
Publicado: (2022)

Molecular Subtypes Based on the Stemness Index Predict Prognosis in Glioma Patients
por: Tan, Jun, et al.
Publicado: (2021)

Identification and Validation of Ferroptosis-Related Subtypes and a Predictive Signature in Hepatocellular Carcinoma
por: Zheng, Chunlan, et al.
Publicado: (2023)

Construction of a T-cell exhaustion-related gene signature for predicting prognosis and immune response in hepatocellular carcinoma
por: Kuang, Tianrui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4sfaq1fbh58lio6tvi3dercr7q